Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kishore Malyavantham

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2013
Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFNLong Shen, Lakshmanan Suresh, Kishore Malyavantham, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2014
Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndromeLong Shen, Efstathia K Kapsogeorgou, Meixing Yu, et al.
BMC Ophthalmology|March 9, 2017
Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyesSandra Everett, Sahana Vishwanath, Vanessa Cavero, et al.
Journal of Neurochemistry|July 8, 2005
Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal deathGennaro Giordano, Ana María Sánchez-Pérez, Carmina Montoliu, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune MyopathiesMichael Mahler, Kishore Malyavantham, Andrea Seaman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two CohortsJesus J Gomar, Marc L Gordon, Erica Christen, et al.
Schizophrenia Research|February 13, 2021
The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigensCarolin Hoffmann, Shenghua Zong, Marina Mané-Damas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2013
Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFNLong Shen, Lakshmanan Suresh, Kishore Malyavantham, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2014
Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndromeLong Shen, Efstathia K Kapsogeorgou, Meixing Yu, et al.
BMC Ophthalmology|March 9, 2017
Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyesSandra Everett, Sahana Vishwanath, Vanessa Cavero, et al.
Journal of Neurochemistry|July 8, 2005
Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal deathGennaro Giordano, Ana María Sánchez-Pérez, Carmina Montoliu, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune MyopathiesMichael Mahler, Kishore Malyavantham, Andrea Seaman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two CohortsJesus J Gomar, Marc L Gordon, Erica Christen, et al.
Schizophrenia Research|February 13, 2021
The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigensCarolin Hoffmann, Shenghua Zong, Marina Mané-Damas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studyNicholas J Ashton, Ashvini Keshavan, Wagner S Brum, et al.
Pageof 2